
In our medical generation it has seemed that the pulmonary disease specialists might work themselves out of a job. First, they all but eliminated most complications of the pneumonias. Then they used streptomycin, isoniazid, and aminosalicylic acid so skillfully that most tuberculosis sanitoriums were forced to close. But nature, in characteristic top form, found the flaw —in those of us who escaped empyema, bronchiectasis, or tuberculosis so that we could live long enough to smoke too many cigarettes for too many years. As a result some of us are destined to become blue bloaters, others pink puffers. And, whatever form of chronic respiratory disorder we may have, many of us are candidates for chronic pulmonary insufficiency or, worse, acute respiratory failure. Although he is well qualified to do so, Giles Filley (with collaboration from Drs. Roger Mitchell, Tom Petty, John Weil, Bernard E. Levine, and D. Boyd Bigelow) has not
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
